Prevalence of HTLV-1/2 infection in pregnant women in Central and South America and the Caribbean : a systematic review and meta-analysis
Copyright © 2024. Published by Elsevier Ltd..
BACKGROUND: Human T-lymphotropic viruses (HTLV)-1 infection is endemic in many countries of Central and South America and Caribbean (CSA&C). Neither screening nor surveillance programs exist for HTLV-1/2 infection among pregnant women in this region. Neither in Western nations with large migrant flows from HTLV-1/2 endemic regions.
METHODS: Systematic review and meta-analysis of the prevalence of HTLV-1/2 infection among CSA&C pregnant women. We included studies searching EMBASE, PubMed/MEDLINE, Scopus, and Web of Science from inception to February 15, 2023. This systematic review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guidelines.
RESULTS: We identified a total of 620 studies. Only 41 were finally included in the meta-analysis. Most studies (61.0%) were from Brazil and Peru (14.6%). The total number of participants was 343,707. The pooled prevalence of HTLV-1/2 infection among CSA&C pregnant women was 1.30% (95% CI: 0.96-1.69) using anti-HTLV-1/2 antibody screening tests. There was a high heterogeneity (I2 = 98.6%). Confirmatory tests gave an HTLV-1 infection rate of 1.02% (95% CI: 0.75-1.33).
CONCLUSIONS: The prevalence of HTLV-1/2 infection among CSA&C pregnant women is 1.3%, most cases being HTLV-1. This rate is greater than for other microbial agents regularly checked as part of antenatal screening (such as HIV, hepatitis B, or syphilis). Thus, HTLV-1/2 antenatal testing should be mandatory among CSA&C pregnant women everywhere.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:143 |
---|---|
Enthalten in: |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 143(2024) vom: 22. März, Seite 107018 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sánchez-Núñez, Juan-Pablo [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antenatal screening |
---|
Anmerkungen: |
Date Revised 12.04.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1016/j.ijid.2024.107018 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370121767 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370121767 | ||
003 | DE-627 | ||
005 | 20240413232622.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240325s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijid.2024.107018 |2 doi | |
028 | 5 | 2 | |a pubmed24n1374.xml |
035 | |a (DE-627)NLM370121767 | ||
035 | |a (NLM)38522611 | ||
035 | |a (PII)S1201-9712(24)00089-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sánchez-Núñez, Juan-Pablo |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prevalence of HTLV-1/2 infection in pregnant women in Central and South America and the Caribbean |b a systematic review and meta-analysis |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 12.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright © 2024. Published by Elsevier Ltd. | ||
520 | |a BACKGROUND: Human T-lymphotropic viruses (HTLV)-1 infection is endemic in many countries of Central and South America and Caribbean (CSA&C). Neither screening nor surveillance programs exist for HTLV-1/2 infection among pregnant women in this region. Neither in Western nations with large migrant flows from HTLV-1/2 endemic regions | ||
520 | |a METHODS: Systematic review and meta-analysis of the prevalence of HTLV-1/2 infection among CSA&C pregnant women. We included studies searching EMBASE, PubMed/MEDLINE, Scopus, and Web of Science from inception to February 15, 2023. This systematic review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guidelines | ||
520 | |a RESULTS: We identified a total of 620 studies. Only 41 were finally included in the meta-analysis. Most studies (61.0%) were from Brazil and Peru (14.6%). The total number of participants was 343,707. The pooled prevalence of HTLV-1/2 infection among CSA&C pregnant women was 1.30% (95% CI: 0.96-1.69) using anti-HTLV-1/2 antibody screening tests. There was a high heterogeneity (I2 = 98.6%). Confirmatory tests gave an HTLV-1 infection rate of 1.02% (95% CI: 0.75-1.33) | ||
520 | |a CONCLUSIONS: The prevalence of HTLV-1/2 infection among CSA&C pregnant women is 1.3%, most cases being HTLV-1. This rate is greater than for other microbial agents regularly checked as part of antenatal screening (such as HIV, hepatitis B, or syphilis). Thus, HTLV-1/2 antenatal testing should be mandatory among CSA&C pregnant women everywhere | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Antenatal screening | |
650 | 4 | |a Breastfeeding | |
650 | 4 | |a HTLV-1 | |
650 | 4 | |a Latin America | |
650 | 4 | |a Pregnant women | |
650 | 4 | |a Vertical transmission | |
700 | 1 | |a de-Miguel-Balsa, Eva |e verfasserin |4 aut | |
700 | 1 | |a Soriano, Vicente |e verfasserin |4 aut | |
700 | 1 | |a Lorenzo-Garrido, Edurado |e verfasserin |4 aut | |
700 | 1 | |a Giménez-Richarte, Angel |e verfasserin |4 aut | |
700 | 1 | |a Otero-Rodriguez, Silvia |e verfasserin |4 aut | |
700 | 1 | |a Celis-Salinas, Juan-Carlos |e verfasserin |4 aut | |
700 | 1 | |a de-Mendoza, Carmen |e verfasserin |4 aut | |
700 | 1 | |a Casapia-Morales, Martin |e verfasserin |4 aut | |
700 | 1 | |a Ramos-Rincón, José Manuel |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases |d 1998 |g 143(2024) vom: 22. März, Seite 107018 |w (DE-627)NLM094730857 |x 1878-3511 |7 nnns |
773 | 1 | 8 | |g volume:143 |g year:2024 |g day:22 |g month:03 |g pages:107018 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijid.2024.107018 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 143 |j 2024 |b 22 |c 03 |h 107018 |